Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning

Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients.Cancer vaccine research in the lab at the Moderna Inc. headquarters in Cambridge, Mass.